Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
uAPRqt3k4wCjZ7hd
Écouter
Français